MindWalk Holdings Corp. (HYFT)

US — Healthcare Sector
Peers: FBIO  NTRB  XBIT  IMUX  IMA  UNCY  CRVO  IFRX  RPTX  LITS 

Automate Your Wheel Strategy on HYFT

With Tiblio's Option Bot, you can configure your own wheel strategy including HYFT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HYFT
  • Rev/Share 0.4857
  • Book/Share 0.4494
  • PB 4.5152
  • Debt/Equity 0.1795
  • CurrentRatio 2.1719
  • ROIC -0.4315

 

  • MktCap 93664537.388
  • FreeCF/Share -0.2084
  • PFCF -9.7395
  • PE -3.2081
  • Debt/Assets 0.0914
  • DivYield 0
  • ROE -1.143

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
HYFT
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial Officer (CFO), effective October 20, 2025. “Scott's extensive experience leading financial strategy for high-growth, publicly traded healthcare and technology companies makes him an ideal addition to our executive team,” said Dr. Jennifer Bath, MindWalk CEO. “His proven abilit.

Read More
image for news MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
MindWalk Holdings Corp. (HYFT) ImmunoPrecise Antibodies Ltd. - Shareholder/Analyst Call Prepared Remarks Transcript
HYFT
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Neutral

MindWalk Holdings Corp. (NASDAQ:HYFT ) ImmunoPrecise Antibodies Ltd. - Shareholder/Analyst Call October 9, 2025 1:00 PM EDT Company Participants Jennifer Bath - CEO, President & Non-Independent Director Presentation Operator Ladies and gentlemen, thank you for standing by.

Read More
image for news MindWalk Holdings Corp. (HYFT) ImmunoPrecise Antibodies Ltd. - Shareholder/Analyst Call Prepared Remarks Transcript
MindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call Transcript
HYFT
Published: September 15, 2025 by: Seeking Alpha
Sentiment: Neutral

MindWalk Holdings Corp. (NASDAQ:HYFT ) Q1 2026 Earnings Call September 15, 2025 10:30 AM EDT Company Participants Jennifer Bath - CEO, President & Non-Independent Director Joseph Scheffler - Interim Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and thank you for joining us today for MindWalk's First Quarter Fiscal 2026 Earnings Call.

Read More
image for news MindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call Transcript
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates
HYFT
Published: September 15, 2025 by: Zacks Investment Research
Sentiment: Negative

MindWalk Holdings Corp. (HYFT) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.11 per share a year ago.

Read More
image for news MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates

About MindWalk Holdings Corp. (HYFT)

  • IPO Date 2002-01-07
  • Website https://www.mindwalkai.com
  • Industry Biotechnology
  • CEO Jennifer Lynne Bath
  • Employees 81

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.